Routine hepatitis B immunisation in India: cost-effectiveness assessment.
Indian J Pediatr
;
2000 Apr; 67(4): 299-300
Article
in English
| IMSEAR
| ID: sea-81723
ABSTRACT
Based on World Bank guidelines, hepatitis B immunization would be an excellent public health investment, saving each life year for well below the per-capita gross domestic product. This would be one of the most cost-effective investments India could make in the field of health.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Humans
/
Child
/
Cost-Benefit Analysis
/
Hepatitis B Vaccines
/
Immunization Programs
/
India
Type of study:
Health economic evaluation
Country/Region as subject:
Asia
Language:
English
Journal:
Indian J Pediatr
Year:
2000
Type:
Article
Similar
MEDLINE
...
LILACS
LIS